Generate Biomedicines, Inc. (GENB) vs Novocure Ltd (NVCR)
A side-by-side comparison of Generate Biomedicines, Inc. and Novocure Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GENB
Generate Biomedicines, Inc.
$14.01HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
NVCR
Novocure Ltd
$15.16HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
Total return — GENB vs NVCR
growth of $100 · dividends reinvested · last 1yGENB +10.0% (+10.0%/yr)NVCR +11.2% (+11.2%/yr)NVCR compounded faster over this window
GENB NVCR
GENB vs NVCR: by the numbers
- •GENB is the larger company ($1.80B vs $1.76B market cap).
- •Both run net losses; NVCR's is the smaller (-21.25% vs -636.99% net margin).
Metrics side by side
Valuation
| Metric | GENB | NVCR |
|---|---|---|
| P/S ratio | N/A | 2.52 |
| P/B ratio | 3.94 | 5.22 |
Profitability
| Metric | GENB | NVCR |
|---|---|---|
| Gross margin | 100.00% | 76.13% |
| Operating margin | -737.04% | -22.08% |
| Net margin | -636.99% | -21.25% |
| ROE | N/A | -43.94% |
| ROIC | -94.79% | -26.88% |
Growth (annualized)
| Metric | GENB | NVCR |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.12% |
| Total return CAGR (5Y) | N/A | -32.71% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.